baber/WOPTO huggingface dataset:
Patent CA-3107522-A1 (CA)
Inventor: GRANT SEAN
IPC: G16H50/30
Filed: 2021-01-29
Abstract: A wearable biometrics device is provided. A wearable biometrics device, for executing processes based on one or more of a user's biometric identifiers comprising a transceiver coupled to a user such that the transceiver extracts the one or more biometric identifiers from the user. The transceiver is coupled to a remote server such that the one or more biometric identifiers are processed and monitored. The remote server comprising a database for storing the one or more biometric identifiers for the user and a projection apparatus coupled to the transceiver such that a projection emitted by the projection apparatus is initiated and manipulated based on the one or more biometric identifiers.
Patent CA-3109466-A1 (CA)
Inventor: IVRI NOAM
IPC: H04W36/00
Filed: 2018-08-13
Abstract: L'invention concerne un dispositif de routage destiné à être installé sur une plate-forme mobile, ledit dispositif se connectant à multiples dispositifs d'accès sans fil pour une interconnexion sans fil avec un réseau étendu (WAN). Le dispositif de routage achemine un trafic vers le réseau WAN par le biais d'un dispositif d'accès sans fil actif parmi les dispositifs d'accès sans fil. Le dispositif de routage surveille la qualité de connexion entre chacun des dispositifs d'accès sans fil et le réseau WAN et, à la suite de la mesure de qualité de connexion pour le dispositif d'accès sans fil au niveau du port actif, tombant en dessous d'une valeur de seuil, il convient de reconfigurer le dispositif de routage pour acheminer un trafic de données vers le réseau WAN par le biais d'un dispositif d'accès sans fil au niveau d'un port ciblé parmi les ports, différent du port actif parmi les ports.
Patent CA-3109638-A1 (CA)
Inventor: ARSALAN MUHAMMAD
IPC: E21B33/068
Filed: 2019-08-13
Abstract: A system including a bottom hole assembly (101) and a ram (103) positioned below a barrier (105) of a well and methods for deploying the same are described. The ram (103) is configured to secure the bottom hole assembly (101) at an end of the bottom hole assembly to secure the bottom hole assembly (101) within the well.
Patent CA-3111767-A1 (CA)
Inventor: LISZKAI TAMAS
IPC: F16L23/032
Filed: 2018-12-14
Abstract: A raised face flange assembly comprises an upper flange (11) to couple to a lower flange (12) using one or more bolts (5): wherein the upper flange (11) or the lower flange (12) comprises: a bolting face (25) defining one or more openings for the one or more bolts (5), respectively; a pair of raised faces (21, 22) including a first raised face and a second raised face to make contact with a mating surface of the other of the upper flange (11) or the lower flange (12); wherein a distance between an area of the second raised face (22) and a plane corresponding to the bolting face (25) is greater than a distance between an area of the first raised face (21) and the plane to distribute contact force with a mating surface over the area of the second raised face (22) to maintain a seal.
Patent CA-3113056-A1 (CA)
Title: Abrasion resistant steel having excellent hardness and impact toughness and manufacturing method therefor
Inventor: YU SENG-HO
IPC: C22C38/06
Filed: 2019-09-23
Abstract: One embodiment of the present invention provides an abrasion resistant steel having excellent hardness and impact toughness, and a manufacturing method therefor, the abrasion resistant steel comprising, by wt%, 0.33-0.42% of carbon (C), 0.1-0.7% of silicon (Si), 0.6-1.6% of manganese (Mn), 0.05% or less of phosphorus (P) (excluding 0), 0.02% or less of sulfur (S) (excluding 0), 0.07% or less of aluminum (Al) (excluding 0), 0.55-5.0% of nickel (Ni), 0.01-1.5% of copper (Cu), 0.01-0.8% of chromium (Cr), 0.01-0.8% of molybdenum (Mo), 50 ppm or less of boron (B) (excluding 0), and 0.02% or less of cobalt (Co) (excluding 0), further comprising one or more selected from the group consisting of 0.02% or less of titanium (Ti) (excluding 0), 0.05% or less of niobium (Nb) (excluding 0), 0.05% or less of vanadium (V) (excluding 0) and 2-100 ppm of calcium (Ca), and comprising the balance of Fe and other inevitable impurities, wherein C and Ni satisfy the following relation 1, and the microstructure comprises 95 area% or more of martensite and 5% or less of bainite (including 0%). [Relation 1] [C]×[Ni] = 0.231
Patent CA-3113676-A1 (CA)
Inventor: RIVERA-FELICIANO JOSE
IPC: C12Q1/68
Filed: 2019-09-23
Abstract: L'invention concerne un gène et un produit génique non caractérisés précédemment qui augmentent la clairance du glucose sanguin indépendamment de l'insuline. L'invention concerne également une méthodologie d'enrichissement en ARNm transcrivant des protéines excrétées et liées à la membrane ainsi qu'un animal non humain exprimant une protéine SEC61b marquée.
Patent CA-3115988-A1 (CA)
Title: Illuminated contact lens and system for improved eye diagnosis, disease management and surgery
Inventor: SCHADLU RAMIN
IPC: A61B3/125
Filed: 2019-10-14
Abstract: A new ocular contact lens has been designed to increase the amount of light reaching the retina. The contact lens edge is chamfered to redirect and increase the light reaching the retina. A light source encircles and contacts the straight or curved chamfered edge. Additionally, a reflective cylinder and its top wall encircle the lens to block any loss of light. This distal edge of the contact lends may be rounded to increase the angle of retina visible. A new ocular imaging camera has a low-light camera subassembly with server, a photosensor next to low-light camera, a short cylindrical housing, a space between the camera subassembly and the housing, an internal program in server to detect good or poor image quality and an alarm for poor image quality, wherein an operator recaptures the image.
Patent CA-3117893-A1 (CA)
Inventor: YOSHIDA TATSURO
IPC: A01N1/02
Filed: 2019-11-18
Abstract: This application provides methods, compositions, and kits for use blood group determination and the preparation of improved red blood cell containing reagents for use in blood typing of blood prior to its use in transfusion medicine.
Patent CA-3119066-A1 (CA)
Inventor: KARLEN STEVEN D
IPC: C07G1/00
Filed: 2019-11-08
Abstract: The invention is directed to BAHD acyltransferase enzymes, nucleic acids encoding BAHD acyltransferase enzymes, and inhibitory nucleic acids adapted to inhibit the expression and/or translation of BAHD acyltransferase RNA; expression cassettes, plant cells, and plants that have or encode such nucleic acids and enzymes; and methods of making and using such nucleic acids, enzymes, expression cassettes, cells, and plants.
Patent CA-3121699-A1 (CA)
Title: Multispecific antigen-binding molecules
Inventor: BULTMANN ANDREAS
IPC: C07K16/46
Filed: 2019-12-04
Abstract: Novel antigen-binding molecules are provided, with the ability to target different antigens with different valency, e.g. one antigen monovalently and another antigen bivalently.
Patent CA-3123415-A1 (CA)
Title: Lighting device for a false ceiling, false ceiling comprising such lighting device and method for fitting such lighting device
Inventor: MICHAUD DENNIS
IPC: F21V15/01
Filed: 2018-11-07
Abstract: Lighting device (22) for a false ceiling (10) comprising a plurality of T-profiles (14) having respective longitudinal axes (A) and arranged in a square mesh grid (12), in which each T-profile (14) has a lower wall with a width (W) and in which the grid (12) has a center distance (D) between the longitudinal axes (A) of T-profiles (14) parallel and adjacent to one another, in which the lighting device (22) has an elongated parallelepiped shape with a width (W') comparable to the width (W) of said T-profiles (14), a height (h) of less than 15 mm and a length (D') comparable to said center distance (D) between the longitudinal axes (A) of T-profiles (14) parallel and adjacent to one another, and in which said lighting device (22) is capable of being fitted directly in contact with the lower wall of a respective T-profile (14).
Patent CA-3124476-A1 (CA)
Title: Air quality improvement for pressurized aircraft
Inventor: CADIEUX DANIEL
IPC: B08B9/027
Filed: 2019-06-03
Abstract: Disclosed is a method including sampling the air of a pressurized zone of an aircraft by identifying a pre-existing pressurized air flow in a pressurized zone of an aircraft without substantially blocking the pre-existing pressurized air flow and creating a data record that can be used when cleaning the cabin air ducts using cleaning techniques suitable for cleaning the respective air duct elements using a sequence of cleaning acts suitable for cleaning select elements of the cabin air ducts. The data record includes identification information which can be used to report incidents to the relevant aviation authority.
Patent CA-3125932-A1 (CA)
Inventor: OZAKI JOSUKE
IPC: G02F1/025
Filed: 2020-01-08
Abstract: La présente invention aborde le problème de détérioration des caractéristiques haute fréquence d'un modulateur optique provenant d'une impédance incohérente entre une ligne haute fréquence et une résistance de borne. L'invention concerne un modulateur optique de Mach-Zehnder à semi-conducteur comprenant : des lignes conductrices côté entrée 20-32 ; des lignes d'électrode de modulation de phase 24-27 ; des lignes conductrices côté sortie 28-31 ; des électrodes 32-35 qui appliquent respectivement des signaux de modulation propagés à travers les lignes d'électrode de modulation de phase 24-27 à des guides d'ondes 16-19 ; et des lignes de masse 48-50. En outre, au moins l'une parmi une couche semi-conductrice de type n ou une couche semi-conductrice de type p est formée successivement entre un substrat de couche inférieure des lignes conductrices côté sortie 28-31 et une couche diélectrique de façon à suivre le long des lignes conductrices côté sortie 28-31.
Patent CA-3127532-A1 (CA)
Title: 4,5,6,7-tetrahydro[1-3]thiazolo[5.4-c]pyridine-2-yl urea compounds and use of thereof as sirtuin activators
Inventor: KAWAI JUNYA
IPC: A61K31/5386
Filed: 2020-01-23
Abstract: The present invention addresses the problem of providing a compound that is useful as an active ingredient for preventing and treating inflammatory diseases and that has a specific chemical structure having an effect of activating SIRT6. The present invention pertains to a compound represented by formula (1), or a pharmaceutically acceptable salt thereof (each symbol in formula (1) is identical to that defined in the description).
Patent CA-3127615-A1 (CA)
Title: Modular wall systems having thick and thin walls
Inventor: GOSLING GEOFF W
IPC: E04B2/74
Filed: 2020-02-12
Abstract: A pre-fabricated wall system that joins wall modules of different thicknesses can include a thin wall module having a depth defined by a distance from a front face thereof to a back face thereof, a thick wall module having a depth that is greater than the depth of the thin wall module, and a vertical connection post. The vertical connection post can include a first connection interface on a first side configured to secure to the thin wall module and a second connection interface on a second side opposite the first side configured to secure to the thick wall module. The thin wall module and the thick wall module can be arranged parallel or co-planar to one another when both the thin wall module and the thick wall module are secured to the vertical connection post.
Patent CA-3130061-A1 (CA)
Title: Macrolides and methods of their preparation and use
Inventor: MYERS ANDREW G
IPC: C07H17/08
Filed: 2014-04-04
Abstract: Provided herein are methods of preparing macrolides by the coupling of an eastern and western half, followed by macrocyclization, to provide macrolides, including both known and novel macrolides. Intermediates in the synthesis of macrolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using the inventive macrolides are also provided. A  general diastereoselective aldol methodology used in the synthesis of the western half is further provided.
Patent CA-3132824-A1 (CA)
Title: Remote sensing of plant photosynthetic capacity
Inventor: LIRAN ODED
IPC: G01N21/64
Filed: 2020-04-07
Abstract: A system comprising: at least one hardware processor; and a non-transitory computer- readable storage medium having stored thereon program instructions, the program instructions executable by the at least one hardware processor to: receive, as input, spectral image data representing spectral reflectance associated with at least one plant, calculate a first and second chlorophyll fluorescence indices in respective first and second wavelength bands, based, at least in part, on said spectral reflectance, and derive a quantum yield value with respect to said at least one plant, by: (i) dividing said first chlorophyll fluorescence index in a sum of said first and second chlorophyll fluorescence indices, and (ii) multiplying (i) by a vegetation index value associated with said at least one plant.
Patent CA-3134940-A1 (CA)
Inventor: RATZ J BRENT
IPC: A61F2/24
Filed: 2020-03-25
Abstract: This disclosure relates generally to prosthetic valves and methods and systems for deploying, positioning, and recapturing the same. A prosthetic valve includes one or more support structures. At least one of the one or more support structures defines an elongate central passageway of the prosthetic valve. The prosthetic valve can also include a plurality of leaflet elements attached to at least one of the one or more support structures and disposed within the elongate central passageway for control of fluid flow through the elongate central passageway. At least one of the one or more support structures is configured to biodynamically fix the prosthetic valve within a native valve such as, for example, a native tricuspid valve of a heart.
Patent CA-3136070-A1 (CA)
Inventor: MALEKI SINA
IPC: H04W72/12
Filed: 2020-04-02
Abstract: Embodiments include methods, performed by a network node in a wireless network, for managing energy consumption of user equipment (UEs) served by the network node. Such methods include transmitting, to a UE, a configuration including one or more time-domain resource allocations (TDRAs). The TDRAs include one or more first scheduling offsets and one or more second scheduling offsets between a scheduling message and a signal or channel scheduled via the scheduling message. A minimum value of the second scheduling offsets is greater than a minimum value of the first scheduling offsets. Such methods also include transmitting, to the UE, an indication of whether the UE should use the first scheduling offsets or the second scheduling offsets, and a first scheduling message that schedules a first signal or channel for the UE according to the indication. Embodiments also include complementary methods perform by UEs, as well as network nodes and UEs.
Patent CA-3137426-A1 (CA)
Title: Method for signaling rectangular slice partitioning in coded video stream
Inventor: CHOI BYEONGDOO
IPC: H04N19/50
Filed: 2021-02-15
Abstract: A method, computer program, and computer system is provided for coding video data. Video data including one or more subpictures is received. A number of the subpictures and a delta value between the number of subpictures and a number of rectangular slices are signaled. The number of rectangular slices is derived based on the number of subpictures and the delta value.
Patent CA-3140285-A1 (CA)
Inventor: SEGARRA DE LA PENA DAVID
IPC: A61P21/00
Filed: 2020-05-16
Abstract: La présente invention concerne des méthodes pour traiter, prévenir (par exemple supprimer, inhiber ou retarder), ou améliorer les symptômes d'une maladie ou d'un état médié par TLR-4, comprenant l'administration d'un aptamère de la présente invention à un sujet qui en a besoin, seul ou en combinaison avec d'autres interventions pharmacologiques et/ou chirurgicales. Dans un aspect particulier, les aptamères de la présente invention sont administrés avant, pendant ou après des interventions pharmacologiques et/ou chirurgicales (par exemple, une thrombolyse telle qu'une thrombectomie) ou toute combinaison associée, pour le traitement de maladies ou d'états ischémiques (par exemple, infarctus du myocarde ou accident ischémique cérébral), hémorragiques (par exemple, accident hémorragique ou transformation hémorragique), ou neurodégénératifs (par exemple, sclérose en plaques). L'invention concerne également des doses et régimes posologiques spécifiques.
Patent CA-3142076-A1 (CA)
Inventor: BROWN POWEL H
IPC: A61K9/48
Filed: 2019-06-11
Abstract: La présente invention concerne des combinaisons d'agents actifs pour le traitement amélioré de cancers Her2 + et des procédés de traitement associés. Les combinaisons comprennent un agoniste de RXR et un agent thérapeutique ciblant Her2 et peuvent éventuellement comprendre en outre une hormone thyroïdienne.
Patent CA-3150814-A1 (CA)
Inventor: BROWN DAVID
IPC: H01M4/04
Filed: 2020-08-12
Abstract: Described is a process mixture for use in and/or for the manufacture of one or more dry films, an article for use in an electrochemical device, a method for making a dry film or an article for an electrochemical device. The dry films can be incorporated in an article. The article can be incorporated in an electrochemical device. The process mixture ingredients may comprise one or more reactive materials and/or reactive composites. The reactive composite may comprise one or more reactive materials and one or more matrix materials. The reactive composite or the process mixture may comprise one or more binders. The process mixture may be a dry blend or a paste. One or more binders may be fibrillizable and/or is fibrillized. The dry blend may be made from a paste. The article may comprise a dry film derived from a process mixture. The dry film may be an element of an anode and/or a cathode. The method may comprise the steps of preparing a process mixture by mixing the ingredients present in process mixture in a mixer and then forming the process mixture into the film of an article of the invention in a film former. One or more of the reactive composites, may be produced by separately mixing one or more matrix materials and one or more reactive materials in a mixer to form a wet or dry reactive composite. The method may further comprise the step of applying the film to a final substrate. The film may be sheared during film forming and/or film application to fully or partially fibrillizes some or all of the one or more fibrillizable binders. An electrochemical device may comprise any of the process mixture, dry films or articles of the invention.
Patent CA-3151909-A1 (CA)
Title: Procede therapeutique ou prophylactique pour le diabete utilisant la polytherapie
Inventor: MERA YASUKO
IPC: A61K31/501
Filed: 2020-09-03
Abstract: Un but de la présente invention consiste à fournir la thérapie ou la prophylaxie du diabète, de l'obésité, ou des complications diabétiques. La présente invention fournit : un médicament thérapeutique ou prophylactique qui sert au diabète, à l'obésité, ou aux complications diabétiques, et qui est caractérisé par l'utilisation combinée d'un inhibiteur SGLT1 et d'au moins un médicament sélectionné parmi les inhibiteurs SGLT2 et les inhibiteurs DPP4 ; et un procédé thérapeutique ou prophylactique qui sert au diabète, à l'obésité, ou aux complications diabétiques, et qui est caractérisé par l'administration d'un inhibiteur SGLT1 et d'au moins un médicament sélectionné parmi les inhibiteurs SGLT2 et les inhibiteurs DPP4.
Patent CA-3151927-A1 (CA)
Title: Amyloid-beta antibodies
Inventor: NICHOLS MICHAEL R
IPC: A61P25/00
Filed: 2020-08-20
Abstract: Provided herein are antibodies selective for Aß protofibrils, compositions containing the antibodies and methods of using the antibodies.
Patent CA-3153537-A1 (CA)
Title: Systems and methods for extraction of biomass materials
Inventor: FUCHS GREG
IPC: B01D11/02
Filed: 2020-09-05
Abstract: Some variations provide a system for extracting a product from biomass, comprising: a process chamber having an internal volume; one or more mechanical elements configured to controllably and reversibly mechanically seal the process chamber and reduce the internal volume to mechanically compress the biomass; a fluid port in flow communication with the process chamber; and a collection subsystem in flow communication with the fluid port. Other variations provide a method of extracting a product from biomass, the method comprising: introducing biomass into a process chamber; mechanically sealing the process chamber; mechanically compressing the biomass to release a first fluid material; mechanically decompressing the biomass; introducing an extraction solvent into the process chamber; maintaining process-chamber pressure from about 1 bar to about 1000 bar, wherein the extraction solvent extracts a second fluid material; and recovering the second fluid material from the process chamber. High processing throughput is enabled with this invention.
Patent CA-3153618-A1 (CA)
Inventor: FLECK MARTIN THOMAS
IPC: C07D495/04
Filed: 2020-10-14
Abstract: The present application relates to thienopyrimidinones and their use as inhibitors of TRPA1 activity, pharmaceutical compositions containing the same and methods of using the same as agents for treatment and/or prevention of fibrotic diseases, inflammatory and auto-immune diseases and CNS-related diseases.
Patent CA-3154790-A1 (CA)
Inventor: WINDOLF MARKUS
IPC: A61B90/00
Filed: 2020-10-16
Abstract: L'invention concerne un dispositif (1) de mesure, de traitement et de transmission de paramètres d'implants en ostéosynthèse, le dispositif (1) comprenant : un boîtier stérilisable biocompatible (2) ; un capteur de contrainte (3) ; une unité électronique (4) pour traiter des signaux électriques fournis par le capteur de contrainte (3), le boîtier (2) comprenant (i) une partie de mesure (5) de la hauteur H5 comprenant une cavité (51) ; et (ii) une partie compartiment (6) de la hauteur H6 comportant une cavité (61), et la partie de mesure (5) comprenant au moins deux moyens de fixation (7) pour fixer le dispositif (1) à un implant et l'unité électronique (4) étant positionnée dans la cavité de la partie compartiment (6).
Patent CA-3155034-A1 (CA)
Inventor: QUATRO FRANK
IPC: G06N5/04
Filed: 2019-10-15
Abstract: Methods and systems for interpreting inputted information are described herein. In some embodiments, a method comprises processing inputted information wherein processing inputted information uses one or more intelligence modules using one or more intelligence models to process the inputted information; making, by the one or more intelligence modules, one or more decisions about inputted information based on the one or more intelligence models; learning, by the one or more intelligence modules, to update the one or more intelligence models; and interpreting inputted information based on the one or more decisions.
Patent CA-3156010-A1 (CA)
Inventor: MATHEU MELANIE P
IPC: B29C64/277
Filed: 2020-09-25
Abstract: L'invention concerne des procédés et des systèmes pour la bio-impression d'organes et d'organoïdes tridimensionnels. L'invention concerne également des organes tridimensionnels bio-imprimés et des organoïdes destinés à être utilisés dans la génération et/ou l'évaluation de produits immunologiques et/ou de réponses immunitaires. L'invention concerne en outre des procédés et un système de bio-impression de matrices tridimensionnelles.